Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin

1. Sicras-Mainar, A.
2. Rejas-Gutiérrez, J.
3. Pérez-Paramo, M.
4. Sánchez-Alvarez, L.
5. Navarro-Artieda, R.
6. Darbà, J.